Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Diabetes, Diabetes, Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 11/8/2017 |
| Start Date: | July 28, 2015 |
| End Date: | April 30, 2018 |
A Phase 1, Multiple Ascending Dose Glucose Clamp Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470 in Comparison to Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes Mellitus
This is a phase 1 multiple ascending dose (MAD) study, conducted in subjects with Type 1 and
Type 2 diabetes mellitus
Type 2 diabetes mellitus
Inclusion Criteria:
- T1DM or T2DM
- Female subjects must be non-pregnant and non-lactating
Exclusion Criteria:
- Pregnant or lactating women
- Participation in an investigational study within 30 days prior to dosing
We found this trial at
1
site
Click here to add this to my saved trials
